Zai Lab
ZLAB
46 hedge funds and large institutions have $247M invested in Zai Lab in 2017 Q3 according to their latest regulatory filings, with 46 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
18.24% more ownership
Funds ownership: 0% → 18.24% (+18%)
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$77.2M |
| 2 |
MAM
Myriad Asset Management
North Point,
Hong Kong
|
+$24.8M |
| 3 |
O
OrbiMed
New York
|
+$18.4M |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$15.5M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$15.4M |
Top Sellers
ZLAB Hedge Fund Activity: Q3 2017 in Review
46 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Zai Lab (ZLAB) for Q3 2017, worth a combined $247M.
Buyers outnumbered sellers: 46 funds opened new ZLAB positions and 0 closed out — a net gain of 46 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $77.2M.
- 46 institutional investors held Zai Lab (ZLAB) as of Q3 2017, up from 0 in Q2 2017.
- Funds reported $247M of Zai Lab stock for Q3 2017.
- 46 funds opened new Zai Lab positions in Q3 2017 and 0 closed out, a net change of +46 holders.
- The largest Zai Lab buyer in Q3 2017 was Fidelity Investments, an estimated $77.2M added.
Based on aggregated 13F filings for Q3 2017.